Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 21Leukemia, Myeloid, Acute 16Leukemia, Myelomonocytic, Chronic 11Myeloproliferative Disorders 4Myelodysplastic-Myeloproliferative Diseases 2Anemia, Refractory, with Excess of Blasts 2Thrombocythemia, Essential 1Systemic Mastocytosis With an Associated Hematologic Neoplasm 1Primary Myelofibrosis 1Polycythemia Vera 1Patient Preference 1Multiple Myeloma 1Leukemia, Biphenotypic, Acute 1GATA2 Deficiency 1Colorectal Neoplasms 1Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

decitabine and cedazuridine drug combination 1avapritinib 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Systemic Mastocytosis With an Associated Hematologic Neoplasm × decitabine and cedazuridine drug combination × Myeloid × Clear all
NCT06327685 2026-04-01

Avapritinib With Decitabine in Patients With SM-AHN

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting
34 enrolled
MyeloidOther hematologic neoplasm

Systemic Mastocytosis With an Associated Hematologic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡